Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Low dose naltrexone therapy in multiple sclerosis.
Is multiple sclerosis an autoimmune disease?
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Neuromyelitis optica with very late onset.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
Risk of vascular disease in patients with multiple sclerosis: a review.
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
Segway use in individuals with multiple sclerosis.
Update on biomarkers in neuromyelitis optica.
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
The role of mitochondria in axonal degeneration and tissue repair in MS.
The use of aminopyridines in neurological disorders.
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
A biopsychosocial model of resilience for multiple sclerosis.
Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming.
Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.

Pages